PRELIMINARY LUNG CANCER RISK ASSESSMENT OF EXPOSURE TO RADON PROGENY FOR TRANSYLVANIA, ROMANIA

Similar documents
Dose conversion factors for radon

UNIVERSITY IN CLUJ Tamás NÉDA, Ildikó MÓCSY, Szende TONK Sapientia University Cluj, Environmental Science Department

RADON AND HEALTH. INFORMATION SHEET October What is radon and where does it come from?

What is Radon? Radon is a gas produced by the radioactive decay of the element radium.

Radon in Homes and Lung Cancer Risk. Sarah C Darby CTSU, University of Oxford

Radon and Cancer: Questions and Answers

The decay of progeny continues until stable, non-radioactive progeny are formed. At each step in the decay process, radiation is released.

Radiation Effects Modulating Factors and Risk Assessment An Overview

EPA ASSESSMENT OF RISKS FROM RADON IN HOMES. June 2003

Figure 1-1. Uranium Decay Series

Lung Cancer and Exposure to Ionizing Radiation

The Radon Calibration Laboratory at the Federal Office for Radiation Protection (BfS)

1. In the general symbol cleus, which of the three letters. 2. What is the mass number of an alpha particle?

Chemistry 1000 Lecture 2: Nuclear reactions and radiation. Marc R. Roussel

Free Executive Summary

THANK YOU. Realtors Protect Families From the Risk of Lung Cancer When Sellers Install Quality Radon Reduction Systems

All aspects on radon. Case 3. Background. Christoffer Baltgren,

Environmental Radiation Risk Assessment

RESIDENTIAL RADON AND LUNG CANCER: END OF THE STORY?

The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning.

RADON Although radon is agas, its decay products are not, and they occur either as unattached

Experiment 10. Radioactive Decay of 220 Rn and 232 Th Physics 2150 Experiment No. 10 University of Colorado

Safety Reports Series No.33

Perspectives of a method for measuring soil-gas radon by an opened counting vial

Radon: The Second Leading Cause of Lung Cancer? Deh, deh, deh, dehhhhh..

ANALYSIS OF POTENTIAL RADIATION-INDUCED GENETIC AND SOMATIC EFFECTS TO HAN FROM MILLING OF URANIUM

Annals of the ICRP ICRP PUBLICATION XXX. Radiological Protection against Radon Exposure. Editor C.H. CLEMENT

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

Rn, Rn and their progeny concentrations in o$ces in Hong Kong

medical diagnostics caesium-137 naturally occurring radio nuclides in the food radon in indoor air potassium in the body

Chapter 15 Radiation in the Environment 1

Incorrect Analyses of Radiation and Mesothelioma in the U.S. Transuranium and Uranium Registries Joey Zhou, Ph.D.

OCCURRENCE OF LUNG CANCER : A POSSIBILITY OF RADIATION HORMESIS

Table 1. Uranium-238 Decay Chain

1. What are the chemical and radiologic characteristics of radon?

Radiation Epidemiology. Radon in homes

Antoine Henri Becquerel was born in Paris on December 15, 1852

Radiation and the Universe Higher Exam revision questions and answers

Environmental Health and Safety Radiation Safety. Module 1. Radiation Safety Fundamentals

Radon from building materials

CRIIRAD report N Analyses of atmospheric radon 222 / canisters exposed by Greenpeace in Niger (Arlit/Akokan sector)

Modeling the Distribution of Environmental Radon Levels in Iowa: Combining Multiple Sources of Spatially Misaligned Data

Update of the scientific evidence on asbestos and cancer. Kurt Straif, MD MPH PhD. The IARC Monographs

METHODS. [Quarterly Journal of Microscopical Science, Vol. 97, part 1, pp , March 1956.]

Indoor exposure to radon from the ground and bronchial cancer in women

Radon in Nordic countries

Sophie ANCELET, IRSN/PRP-HOM/SRBE/LEPID

Distribution of Terminal Lung and Liver Dose Rates in United States Transuranium and Uranium Registries Registrants

The objective of this chapter is to provide criteria with which to assess the safety of

U.S. EPA s Models for Establishing Cleanup Levels in Soil, Water, Buildings and Streets at Superfund Sites

Annals of the ICRP ICRP PUBLICATION 115. Lung Cancer Risk from Radon and Progeny and Statement on Radon. Editor C.H. CLEMENT

short mean lives), emitting alpha particles, which have a high LET. Thus radon causes

Cancer risk associated to radon after exposure in mines or in homes

SR Communications Tower Task Force Dr. Jeff Liva, Allen Cohen, Rebecca Rogers

Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario.

THE TIMES OF OCCURRENCE OF MESOTHELIOMAS IN RATS FOLLOWING INOCULATION WITH ASBESTOS

Radon Gas in Ireland Joint Position Statement by the Radiological Protection Institute of Ireland and the Health Service Executive

HADRON THERAPY FOR CANCER TREATMENT

ANNEX E. Sources-to-effects assessment for radon in homes and workplaces. Contents. Page INTRODUCTION

Radioactive Contamination Uranium Legacy in CA

Endpoint Selection in Phase II Oncology trials

STUDY #2 IN A SERIES OF REPORTS ON RADON IN BC HOMES. Prince George: COMMUNITY-WIDE RADON TESTING RESULTS AS PART OF ITS PROGRAM

Radiation Epidemiology. Radon in homes

Long Term Follow-Up of the Residents of the Three Mile Island Accident Area:

Lecture 2 Macroscopic Interactions Neutron Interactions and Applications Spring 2010

A Non-Technical Explanation of Radon Gas By Dr. Jim Burkhart

Mathematical Modeling of Risk Acceptability Criteria

CHAPTER 2: UNDERSTANDING CANCER

An Introduction to the Estimation of Risks Arising from Exposure to Low Doses of Ionising Radiation

IAEA Safety Standards

A Homeowner s Guide to Radon

[2] At the time of purchase of a Strontium-90 source, the activity is Bq.

Radiological Protection Principles concerning the Natural Radioactivity of Building Materials

Summary Measures (Ratio, Proportion, Rate) Marie Diener-West, PhD Johns Hopkins University

A radiation weighting factor is an estimate of the effectiveness per unit dose of the given radiation relative a to low-let standard.

PRESS NOTE. Scientific Meet on Radiation & Health safety

Medical Physics and Radioactivity

A Citizen s Guide To Radon

Likelihood of Cancer

Distribution of Terminal Lung and Liver Dose Rates in United States Transuranium and Uranium Registries Registrants

Biostatistics and Epidemiology within the Paradigm of Public Health. Sukon Kanchanaraksa, PhD Marie Diener-West, PhD Johns Hopkins University

What you should do if there is a NUCLEAR EMERGENCY at the Devonport Site

The indoor Rn-concentration: schools, kindergartens and official buildings versus homes.

RADIATION AND HEALTH NOVEMBER 1996

New Hampshire Childhood Cancer

Current Usage and Health Significance of the Modern Use of Chrysotile Products: Review of Recently Published Evidence

Prevention and Early Detection. Radiation Exposure and Cancer. Ionizing Radiation. print close

North Carolina Radon-in-Water Advisory Committee Report. March 2011

Talcum Powder and Cancer

R. Julian Preston NHEERL U.S. Environmental Protection Agency Research Triangle Park North Carolina. Ninth Beebe Symposium December 1, 2010

Smoking and Lung Cancer

MEASUREMENT PROTOCOLS FOR RADON IN DWELLINGS IN SWEDEN; THIRTEEN YEARS OF EXPERIENCE

Risks To Lung Cancer - Radon Exposure

Radioactivity III: Measurement of Half Life.

13. Poisson Regression Analysis

In 1946 Harvard physicist Robert Wilson ( ) suggested:

What is radon? Potential impact on human health

The Burden of Occupational Lung Cancer Paul A. Demers, PhD

Qualitätsmanagement-Handbuch

Radiation Protection Dosimetry Advance Access published November 14, Radiation Protection Dosimetry (2008), pp. 1 7

Transcription:

PRELIMINARY LUNG CANCER RISK ASSESSMENT OF EXPOSURE TO RADON PROGENY FOR TRANSYLVANIA, ROMANIA L. A. Truta-Popa*, A. Dinu*, T. Dicu*, K. Szacsvai*, C. Cosma*, W. Hofmann** *Babes-Bolyai University, Department of Environmental Science, Cluj-Napoca, Romania **University of Salzburg, Division of Physics and Biophysics, Salzburg, Austria 1

RADON INHALATION AND LUNG CANCER RISK Fig. 1 Average annual dose from natural sources of radiation to the population of Romania (O. Iacob, 2000) 2

LUNG CANCER AMONG OTHER CANCERS Fig. 2 Age-adjusted cancer death rates for males in Romania (V. M. Nagy, 2007) 3

OBJECTIVES OF THE PRESENT STUDY To assess lung cancer risk due to radon exposure for populations living in selected regions of Transylvania based on measured radon concentrations. To predict lung cancer risk in these areas by using a cancer model based on cellular radiation effects. To estimate the fraction of lung cancer cases in each region based on the total number of reported lung cancers cases in Romania and the number of people living in these regions. 4

REGIONS IN TRANSYLVANIA INVESTIGATED The uranium mine from Stei causes a percentage of about 30% of subjects living in the neighboring dwellings be exposed at elevated radon levels > 200 Bq m -3. Fig. 3 Investigated areas in Romania 5

MEASUREMENT OF RADON CONCENTRATIONS Indoor radon concentrations were measured in 667 dwellings of these areas, using CR-39 track detectors, exposed for a minimum of 3 months. The development process and the automatic reading of all detectors was performed with the RadoSys-2000 equipment. The equilibrium factor was F 0.4. Table 1. Measured radon concentrations in the investigated areas and mean annual radon concentrations 6

AVERAGE RADON CONCENTRATIONS The mean measured radon concentration values (*) were corrected for seasonal variations, with: 3 C = C summer 3 C = C int er 2 w 4 (C. Cosma et al., 2009) The weighted average annual Rn-222 concentrations were estimated, for each area/county: Fig. 4 Average annual Rn concentration [Bq/m 3 ] for the investigated areas 7

CONVERSION OF RADON CONCENTRATIONS To establish a dose-effect relationship and hence to assess the lifetime lung cancer risks for the populations in the mentioned areas/counties, measured Rn-222 concentrations were converted into: exposure, 1 WLM 230 Bq/m 3 (ICRP 65, 1994) absorbed dose, 1 WLM = 5 mgy (E. L. Alpen, 1998) 8

FROM CELLULAR RADIATION EFFECTS TO LUNG CANCER RISK Transformation frequencies for alpha particles: Experimental data: in-vitro transformation frequencies per surviving cell: TFS For in-vivo exposure we need transformation frequencies per exposed cell: TFE TFE = TFS exp(-γd) where γ represents the cell killing efficiency Tissue response: TR From in-vitro transformation in single cells to in-vivo transformation in tissue (stem cell system): In-vitro to in-vivo: from λ 2 (1 day cycle time) to λ 1 (30 days cycle time) Single cell to stem cell system: Replacement of radiation-induced cell killing of neighboring cells by stimulated division of stem cells: from λ 1 (30 days cycle time) to λ 2 (1 day cycle time), where p denotes the probability that a stem cell is forced to divide if an epithelial cell is killed. TR = [λ 1 + λ 2 p (1 - exp(-γd)] / λ 1 9

SINGLE AND MULTIPLE CELLULAR TRAVERSALS Epidemiological studies on lung cancer suggest that in cases of protracted exposures the crucial quantity for cellular radiation effects is the dose per cell cycle. While the number of cells hit increases with the tissue or organ dose, the average dose received by the traversed cells remains constant until multiple alpha particle hits start playing a greater role. This observation questions the applicability of average doses for alpha radiations at the cellular level, where radiobiological effects originate, at sufficiently low doses and thus average dose (D) was replaced by the frequency of single and multiple alpha particle hits. For a given average number of cellular hits ( H ) per cell cycle time during the total exposure period (T), equivalent to the average dose D, the actual number of single and multiple hits (P n ), delivering an average dose D n to a traversed nucleus of a basal or secretory cell during the lifetime of these cells, were selected from a Poisson distribution: P n H = n e n! H H = N h N 0 N h = D Dc where N h is the number of hits during exposure period T, N 0 is the number of cell cycles during exposure period T, is the mean cellular dose per single hit. D c 10

LUNG CANCER RISK (TF-TR) MODEL where: D c n i= 1 ( γ Dn ) { λ1 + λ2 p [ 1 exp( γ Dn )]} / 1 Pn R( D) = C TFS( Dn ) exp λ = 0.33 Gy -1 for cells with a nuclear diameter of 9 μm and an LET of 130 kev/µm and C is a constant scaling factor relating the number of transformed cells at dose D to the occurrence of an observable bronchial tumor, derived from epidemiological studies. 11

COMPARISON BETWEEN EPIDEMIOLOGICAL DATA AND MODEL PREDICTIONS For the comparison of model predictions with epidemiological data for indoor exposures, the data reported by S. Darby et al. (2005) were used. Fig. 5 Comparison between epidemiological data (2005) and model predictions 12

RELATIVE RISK PREDICTIONS FOR THE INVESTIGATED AREAS Fig. 6 Relative risk predictions for the investigated areas 13

PREDICTION OF LUNG CANCER CASES The number of total lung cancer deaths due to indoor exposure to Rn-222 ( where RR 1 RR ( RR 1) = RR N Rn, a NT, a N Rn, a is the fraction of risk attributed to radon (FRA), a is the area where ) is: population is exposed, RR is the relative risk and N T, a is the total annual number of lung cancer deaths in the area a (equation adapted after O. Catelinois et al, and P. Pirard et al., BEH, 2007). The National Institute of Statistics (INSSE) Romania provided: * the annual absolute numbers of lung cancer deaths, * mortality rate for 100.000 people, * the total population for the counties where Rn-222 concentrations were measured. 14

Fig. 7 Percentage of lung cancer deaths due to exposure to radon, for the investigated areas 15

CONCLUSIONS The average annual radon concentrations for the investigated areas/counties were: 232, 114, 71, 62 and 161 Bq/m 3 for Stei area, Cluj, Bistrita-Nasaud, Sibiu, and Alba county, respectively. The relative risks calculated with the TF-TR model for the areas/counties where radon concentrations were measured are: 1.18 for Stei area, 1.08 for Cluj county, 1.05 for Bistrita-Nasaud county, 1.03 for Sibiu county and 1.11 for Alba county. The percentage of lung cancer deaths attributed to radon exposure are: 15.4 for Stei area, 7.0 for Cluj, 4.5 for Bistrita-Nasaud, 2.6 for Sibiu and 9.6 for Alba county. 16